SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Historical Holders from Q1 2019 to Q3 2025

Symbol
SWTX
Type / Class
Equity / Common Stock, par value $.0001 per share
Shares outstanding
75.6M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
40.1K
Holdings value
$2.16M
% of all portfolios
0%
Grand Portfolio weight change
-0.006%
Number of holders
3
Number of sells
-217
Average Value change %
-0.02%
Average sells %
-0.02%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 9.62% $331M 7.16M The Vanguard Group 31 Dec 2024
Hudson Bay Capital Management LP 5.22% $185M 3.94M Hudson Bay Capital Management LP 30 Jun 2025
Deep Track Capital, LP 4.65% $160M 3.46M Deep Track Capital, LP 31 Dec 2024
FMR LLC 1.7% $58.2M 1.26M FMR LLC 30 Apr 2025
GOLDMAN SACHS GROUP INC 0% -93.3% $7.11K -$228M 132 -100% THE GOLDMAN SACHS GROUP, INC. 30 Sep 2025

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 40.1K $2.16M -$3.52B $47.00 3
2025 Q2 75.1M $3.53B +$106M $46.99 221
2025 Q1 73.7M $3.25B -$236M $44.13 304
2024 Q4 80.9M $2.92B -$118M $36.13 214
2024 Q3 80.7M $2.59B +$49.3M $32.04 224
2024 Q2 77.1M $2.91B -$85.6M $37.67 207
2024 Q1 78.3M $3.85B +$167M $49.22 215
2023 Q4 75.4M $2.75B +$378M $36.50 177
2023 Q3 68.5M $1.58B -$32.3M $23.12 146
2023 Q2 69.6M $1.82B +$89.8M $26.22 140
2023 Q1 66.3M $1.7B -$5.02M $25.74 146
2022 Q4 66.6M $1.73B +$78.2M $26.01 136
2022 Q3 63.4M $1.8B +$234M $28.53 143
2022 Q2 55.3M $1.36B +$60.4M $24.62 138
2022 Q1 49.4M $2.79B +$223M $56.44 131
2021 Q4 45.5M $2.82B +$26.8M $61.98 141
2021 Q3 45.1M $2.86B +$40.1M $63.44 139
2021 Q2 44.7M $3.69B +$75.2M $82.41 133
2021 Q1 43.9M $3.23B +$39.7M $73.57 135
2020 Q4 43.4M $3.15B +$421M $72.52 123
2020 Q3 37.4M $1.78B +$128M $47.67 91
2020 Q2 34.8M $1.46B +$82.3M $42.00 77
2020 Q1 33M $891M +$24.8M $27.00 68
2019 Q4 31.9M $1.23B +$28.1M $38.49 56
2019 Q3 31.2M $677M +$677M $21.68 43
2019 Q2 53.9K $4.45M $82.41 1
2019 Q1 53.9K $4.45M $82.41 1